|
[1]
|
梁振宇, 王凤燕, 陈子正, 等. 2023年GOLD慢性阻塞性肺疾病诊断、管理及预防全球策略更新要点解读[J]. 中国全科医学, 2023, 26(11): 1287-1298.
|
|
[2]
|
Adeloye, D., Song, P., Zhu, Y., Campbell, H., Sheikh, A. and Rudan, I. (2022) Global, Regional, and National Prevalence of, and Risk Factors for, Chronic Obstructive Pulmonary Disease (COPD) in 2019: A Systematic Review and Modelling Analysis. The Lancet Respiratory Medicine, 10, 447-458. [Google Scholar] [CrossRef] [PubMed]
|
|
[3]
|
Ge, H., Liu, X., Gu, W., Feng, X., Zhang, F., Han, F., et al. (2021) Distribution of COPD Comorbidities and Creation of Acute Exacerbation Risk Score: Results from SCICP. Journal of Inflammation Research, 14, 3335-3348. [Google Scholar] [CrossRef] [PubMed]
|
|
[4]
|
Agusti, A. and Faner, R. (2019) Lung Function Trajectories in Health and Disease. The Lancet Respiratory Medicine, 7, 358-364. [Google Scholar] [CrossRef] [PubMed]
|
|
[5]
|
GBD 2015 Chronic Respiratory Disease Collaborators (2017) Global, Regional, and National Deaths, Prevalence, Disability-Adjusted Life Years, and Years Lived with Disability for Chronic Obstructive Pulmonary Disease and Asthma, 1990-2015: A Systematic Analysis for the Global Burden of Disease Study 2015. The Lancet Respiratory Medicine, 5, 691-706.
|
|
[6]
|
Singh, D., Agusti, A., Anzueto, A., Barnes, P.J., Bourbeau, J., Celli, B.R., et al. (2019) Global Strategy for the Diagnosis, Management, and Prevention of Chronic Obstructive Lung Disease: The GOLD Science Committee Report 2019. European Respiratory Journal, 53, Article ID: 1900164. [Google Scholar] [CrossRef] [PubMed]
|
|
[7]
|
Agustí, A., Celli, B.R., Criner, G.J., Halpin, D., Anzueto, A., Barnes, P., et al. (2023) Global Initiative for Chronic Obstructive Lung Disease 2023 Report: GOLD Executive Summary. American Journal of Respiratory and Critical Care Medicine, 207, 819-837. [Google Scholar] [CrossRef] [PubMed]
|
|
[8]
|
朵明慧, 李洪鹏, 谭烨. 基于历版GOLD评估的慢性阻塞性肺疾病中医证型与临床特征的研究进展[J]. 现代中西医结合杂志, 2025, 34(1): 130-134+141.
|
|
[9]
|
彭思敏, 赵媚, 许光兰, 等. 基于现代医案挖掘中医药治疗慢性阻塞性肺疾病的证治规律[J]. 中国实验方剂学杂志, 2022, 28(15): 173-182.
|
|
[10]
|
梁剑晨. 中药配方颗粒与中药饮片治疗COPD的临床及实验研究[D]: [硕士学位论文]. 合肥: 安徽中医药大学, 2021.
|
|
[11]
|
沈佳佳. 刘建秋教授对慢性阻塞性肺疾病痰浊阻肺相关证型的辨治[D]: [硕士学位论文]. 哈尔滨: 黑龙江中医药大学, 2017.
|
|
[12]
|
雷灿. 基于数据挖掘探讨李旭成教授治疗慢性阻塞性肺疾病用药规律[D]: [硕士学位论文]. 武汉: 湖北中医药大学, 2023.
|
|
[13]
|
凌小艳, 韩平, 崔晓华. 桃红四物汤合二陈汤加减治疗老年慢性阻塞性肺疾病的临床分析[J]. 时珍国医国药, 2022, 33(7): 1678-1681.
|
|
[14]
|
杨兴嫕, 王士汉, 王琦, 等. 加减涤痰汤治疗慢性阻塞性肺疾病并发II型呼吸衰竭(肺胀病-痰蒙神窍证)的临床研究[J]. 中国中医急症, 2023, 32(11): 1937-1940.
|
|
[15]
|
李建生, 余学庆. 慢性阻塞性肺疾病中医分期分级防治策略[J]. 中医杂志, 2019, 60(22): 1895-1899.
|